PortfoliosLab logoPortfoliosLab logo
XBIT vs. XBIO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

XBIT vs. XBIO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in XBiotech Inc. (XBIT) and Xenetic Biosciences, Inc. (XBIO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, XBIT achieves a -5.44% return, which is significantly lower than XBIO's 36.41% return. Over the past 10 years, XBIT has outperformed XBIO with an annualized return of -16.12%, while XBIO has yielded a comparatively lower -40.33% annualized return.


XBIT

1D
0.89%
1M
-6.22%
6M
-6.22%
YTD
-5.44%
1Y
-22.07%
3Y*
-23.36%
5Y*
-32.53%
10Y*
-16.12%
ALL TIME*
-17.47%

XBIO

1D
5.34%
1M
3.86%
6M
35.78%
YTD
36.41%
1Y
-6.48%
3Y*
-8.31%
5Y*
-39.16%
10Y*
-40.33%
ALL TIME*
-43.33%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$104.51K$74.46K$58.29K
$56.38K$89.23K$78.71K

XBIT vs. XBIO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
XBIT
XBiotech Inc.
-5.44%-39.49%-1.25%13.96%-68.46%-17.46%-16.15%267.42%28.93%-61.07%
XBIO
Xenetic Biosciences, Inc.
36.41%-45.61%15.65%21.01%-77.90%-36.76%41.67%-92.68%-14.54%-55.37%

Correlation

The correlation between XBIT and XBIO is 0.11, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.11

Correlation (3Y)
Balances recent behavior with more history.

0.04

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.09

Correlation (10Y)
Provides a long-term view across more market conditions.

0.09

Correlation (All Time)
Calculated using the full available price history since Apr 15, 2015

0.07

Fundamentals

Market Cap

XBIT:

$68.90M

XBIO:

$5.59M

EPS

XBIT:

-$1.32

XBIO:

-$1.09

PB Ratio

XBIT:

0.51

XBIO:

0.98

Total Revenue (TTM)

XBIT:

$0.00

XBIO:

$3.19M

Gross Profit (TTM)

XBIT:

-$805.00K

XBIO:

$2.38M

EBITDA (TTM)

XBIT:

-$42.42M

XBIO:

-$2.37M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

XBIT vs. XBIO — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

XBIT
XBIT Risk / Return Rank: 2222
Overall Rank
XBIT Sharpe Ratio Rank: 2121
Sharpe Ratio Rank
XBIT Sortino Ratio Rank: 1919
Sortino Ratio Rank
XBIT Omega Ratio Rank: 2020
Omega Ratio Rank
XBIT Calmar Ratio Rank: 2222
Calmar Ratio Rank
XBIT Martin Ratio Rank: 2727
Martin Ratio Rank

XBIO
XBIO Risk / Return Rank: 5050
Overall Rank
XBIO Sharpe Ratio Rank: 4141
Sharpe Ratio Rank
XBIO Sortino Ratio Rank: 6666
Sortino Ratio Rank
XBIO Omega Ratio Rank: 6565
Omega Ratio Rank
XBIO Calmar Ratio Rank: 4040
Calmar Ratio Rank
XBIO Martin Ratio Rank: 4040
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

XBIT vs. XBIO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for XBiotech Inc. (XBIT) and Xenetic Biosciences, Inc. (XBIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


XBITXBIODifference
Sharpe ratioReturn per unit of total volatility

-0.43

Sortino ratioReturn per unit of downside risk

-1.89

Omega ratioGain probability vs. loss probability

0.94

1.17

-0.23

Calmar ratioReturn relative to maximum drawdown

-0.56

-0.08

-0.48

Martin ratioReturn relative to average drawdown

-0.76

-0.10

-0.66

XBIT vs. XBIO - Sharpe Ratio Comparison

The current XBIT Sharpe Ratio is -0.47, which is lower than the XBIO Sharpe Ratio of -0.04. The chart below compares the historical Sharpe Ratios of XBIT and XBIO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

XBIT vs. XBIO - Drawdown Comparison

The maximum XBIT drawdown since its inception was -92.67%, smaller than the maximum XBIO drawdown of -99.95%. Use the drawdown chart below to compare losses from any high point for XBIT and XBIO.


Loading charts...

Drawdown Indicators


XBITXBIODifference

Max Drawdown

Largest peak-to-trough decline

-92.67%

-99.95%

+7.28%

Max Drawdown (1Y)

Largest decline over 1 year

-39.43%

-80.50%

+41.07%

Max Drawdown (3Y)

Largest decline over 3 years

-78.56%

-80.50%

+1.94%

Max Drawdown (5Y)

Largest decline over 5 years

-87.07%

-94.87%

+7.80%

Max Drawdown (10Y)

Largest decline over 10 years

-90.13%

-99.72%

+9.59%

Current Drawdown

Current decline from peak

-91.67%

-99.92%

+8.25%

Average Drawdown

Average peak-to-trough decline

-70.40%

-91.49%

+21.09%

Ulcer Index

Depth and duration of drawdowns from previous peaks

29.19%

65.98%

-36.79%

Volatility

XBIT vs. XBIO - Volatility Comparison

The current volatility for XBiotech Inc. (XBIT) is 4.68%, while Xenetic Biosciences, Inc. (XBIO) has a volatility of 16.49%. This indicates that XBIT experiences smaller price fluctuations and is considered to be less risky than XBIO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


XBITXBIODifference

Volatility (1M)

Calculated over the trailing 1-month period

4.68%

16.49%

-11.81%

Volatility (6M)

Calculated over the trailing 6-month period

18.68%

49.52%

-30.84%

Volatility (1Y)

Calculated over the trailing 1-year period

47.12%

165.47%

-118.35%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

63.85%

100.41%

-36.56%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

73.17%

133.91%

-60.74%

Dividends

XBIT vs. XBIO - Dividend Comparison

Neither XBIT nor XBIO has paid dividends to shareholders.


PositionTTM20252024202320222021
XBIO
Xenetic Biosciences, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%
XBIT
XBiotech Inc.
0.00%0.00%0.00%0.00%0.00%22.46%

Financials

XBIT vs. XBIO - Financials Comparison

This section allows you to compare key financial metrics between XBiotech Inc. and Xenetic Biosciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


XBIT and XBIO have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

XBIO has higher volatility (16.49%) compared to XBIT (4.68%). In terms of maximum drawdown, XBIT dropped -92.67% vs XBIO's -99.95%.

XBIO currently has the higher Sharpe Ratio (-0.04 vs -0.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for XBIT and XBIO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer